Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -295.4-241.8-202.2-83.9-32.8-31.2-26.4-6.8
Depreciation and amortization  0.50.40.50.10.10.1  
Stock-based compensation  31.626.920.722.813.53.37.9 
Change in working capital   [+]97.1109.148.442.614.95.58.62.1
Other operating activities  -58.6-78.5-24.9-23.2-21.2 -7.81.6
Cash from operations  -224.9-183.9-157.6-41.6-25.5-22.3-17.6-3.1
   
Capital expenditures   [+]-0.2-0.2-0.3-0.20.0-0.10.00.0
Sales of short-term investments, net   [+]206.9-4.8160.130.9-380.1-21.915.4 
Other cash from investing        5.9 
Cash from investing  206.7-5.1159.830.7-380.1-22.022.00.0
   
Issuance of common stock, net         0.0
Financing costs  -0.9       
Other cash from financing  312.6171.25.10.2314.3173.814.53.3
Cash from financing  313.5171.25.10.2314.3173.814.53.3
   
Free cash flow  -225.1-184.1-157.9-41.8-25.5-22.4-17.6-3.1
        Per share (diluted)  ($13.13)($11.14)($10.22)($2.71)($1.73)($1.83)($3.38)($18.37)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy